Khosla Backs AI Startup Creating New Class of Genetic Drugs
Heather Mack, Wall Street Journal
In the next 24 months, Mr. Frey said Deep Genomics expects to be able to generate a library of 1,000 oligonucleotide compounds that can be used in different ways, from in-house development of the company’s own drugs to research collaborations and preclinical testing ...